• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

头孢唑肟(FK-749)是治疗由产青霉素酶淋病奈瑟菌引起的尿道炎的有效疗法。

Ceftizoxime (FK-749) is effective therapy for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.

作者信息

Harrison W O, Sanchez P L, Lancaster D J, Kerbs S B, Berg S W

出版信息

Sex Transm Dis. 1984 Jan-Mar;11(1):30-1. doi: 10.1097/00007435-198401000-00007.

DOI:10.1097/00007435-198401000-00007
PMID:6324399
Abstract

Fifty-five men with culture-proved gonococcal urethritis caused by either penicillin-sensitive or penicillinase-producing Neisseria gonorrhoeae were treated with 1 g of ceftizoxime given intramuscularly. All patients were cured, including 26 (47%) with penicillinase-producing strains. Patients experienced no local or systemic side effects and tolerated the injection of ceftizoxime well. These results show that ceftizoxime is an effective alternative to either spectinomycin or cefoxitin in treatment of uncomplicated gonococcal urethritis caused by penicillin-resistant bacteria.

摘要

55名经培养证实患有由青霉素敏感或产青霉素酶的淋病奈瑟菌引起的淋菌性尿道炎的男性,接受了1克头孢唑肟肌肉注射治疗。所有患者均治愈,其中包括26名(47%)感染产青霉素酶菌株的患者。患者未出现局部或全身副作用,对头孢唑肟注射耐受性良好。这些结果表明,在治疗由耐青霉素细菌引起的单纯性淋菌性尿道炎方面,头孢唑肟是大观霉素或头孢西丁的有效替代药物。

相似文献

1
Ceftizoxime (FK-749) is effective therapy for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.头孢唑肟(FK-749)是治疗由产青霉素酶淋病奈瑟菌引起的尿道炎的有效疗法。
Sex Transm Dis. 1984 Jan-Mar;11(1):30-1. doi: 10.1097/00007435-198401000-00007.
2
Cefoxitin as a single-dose treatment for urethritis caused by penicillinase-producing Neisseria gonorrhoeae.头孢西丁单剂量治疗产青霉素酶淋病奈瑟菌引起的尿道炎。
N Engl J Med. 1979 Sep 6;301(10):509-11. doi: 10.1056/NEJM197909063011001.
3
Cefonicid as therapy for uncomplicated gonococcal urethritis caused by penicillinase-producing Neisseria gonorrhoeae.头孢尼西作为产青霉素酶淋病奈瑟菌所致单纯性淋菌性尿道炎的治疗药物。
West J Med. 1984 Feb;140(2):224-6.
4
One gram of cefoxitin cures uncomplicated gonococcal urethritis caused by penicillinase-producing Neisseria gonorrhoeae (PPNG).一克头孢西丁可治愈由产青霉素酶淋病奈瑟菌(PPNG)引起的非复杂性淋菌性尿道炎。
Sex Transm Dis. 1983 Jul-Sep;10(3):135-7. doi: 10.1097/00007435-198307000-00007.
5
Comparison of ceftriaxone with cefoxitin in the treatment of penicillin-resistant gonococcal urethritis.头孢曲松与头孢西丁治疗耐青霉素淋菌性尿道炎的比较。
Br J Vener Dis. 1983 Jun;59(3):176-8. doi: 10.1136/sti.59.3.176.
6
Randomised comparative study of ceftriaxone and spectinomycin in gonorrhoea.头孢曲松与大观霉素治疗淋病的随机对照研究。
Genitourin Med. 1985 Apr;61(2):106-8. doi: 10.1136/sti.61.2.106.
7
Infections with non-penicillinase-producing Neisseria gonorrhoeae treated with cefuroxime: treatment failures.用头孢呋辛治疗非产青霉素酶淋病奈瑟菌感染:治疗失败情况。
Sex Transm Dis. 1982 Oct-Dec;9(4):200-1. doi: 10.1097/00007435-198210000-00007.
8
The combination of rifampicin-erythromycin in the treatment of gonococcal urethritis in men.利福平-红霉素联合治疗男性淋菌性尿道炎
J Med Assoc Thai. 1985 Nov;68(11):579-82.
9
Single 1 g dose of cefotaxime in the treatment of infections due to penicillinase-producing strains of Neisseria gonorrhoeae.单次1克剂量头孢噻肟治疗产青霉素酶淋病奈瑟菌引起的感染。
Br J Vener Dis. 1983 Apr;59(2):100-2. doi: 10.1136/sti.59.2.100.
10
A comparison of penicillin G plus a beta-lactamase inhibitor (sulbactam) with spectinomycin for treatment of urethritis caused by penicillinase-producing Neisseria gonorrhoeae.青霉素G加β-内酰胺酶抑制剂(舒巴坦)与壮观霉素治疗产青霉素酶淋病奈瑟菌所致尿道炎的比较。
Sex Transm Dis. 1984 Oct-Dec;11(4):314-7. doi: 10.1097/00007435-198410000-00011.

引用本文的文献

1
Ceftizoxime interpretive criteria for in vitro susceptibility tests with Neisseria gonorrhoeae.淋病奈瑟菌体外药敏试验的头孢唑肟解释标准。
J Clin Microbiol. 1993 Sep;31(9):2531-2. doi: 10.1128/jcm.31.9.2531-2532.1993.
2
Role of cephalosporins in gonorrhoea and other sexually transmitted diseases.头孢菌素在淋病及其他性传播疾病中的作用。
Drugs. 1987;34 Suppl 2:164-79. doi: 10.2165/00003495-198700342-00013.